Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Go back to Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data| (NASDAQ: BNTX) | Delayed: 88.63 -1.04 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.67 | 52 Week High | $ | |||
| Open | $89.34 | 52 Week Low | $ | |||
| Day High | $89.86 | P/E | N/A | |||
| Day Low | $87.52 | EPS | $ | |||
| Volume | 352,954 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.06 -0.36 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.42 | 52 Week High | $37.39 | |||
| Open | $30.28 | 52 Week Low | $28.25 | |||
| Day High | $30.32 | P/E | 18.22 | |||
| Day Low | $29.81 | EPS | $1.65 | |||
| Volume | 12,464,200 | |||||



